ISTH Congress 2022, London

New publication

“Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication” (W. Mondorf, E. Hermann, C. Escuriola Ettingshausen, F. Ronald, K. Holstein, R. Klamroth, U. Sachs⁾

Presented at the congress by Dr. Carmen Escuriola Ettingshausen: Using the real-life data from our app smart medication eDiary, it could be shown that bleeding episodes in affected patients with hemophilia A declined significantly after switching from FVIII concentrates to emicizumab.

👉 Read the abstract here, opens in a new tab